All News

Experts caution that many unregulated over-the-counter fish oil products have little benefit, with some having no benefit at all.

A survey of new Rx, new generic, and new OTC products

The Ohio commercial activity tax law ("CAT") is an annual tax on the privilege of doing business in Ohio.

Prescriptions could take on a new look if the Office of the Inspector General gets its way.

The EPA is looking for mismanagement of hazardous pharmaceutical waste generated by hospitals and other healthcare facilities. The odds are good that your hospital is in violation.

Technology is the pharmacist's toolbox. Here are some apps to help you extend your care.

The outcry from physicians, pharmacists, and patients over disruptions in supplies of vital medications continues to draw attention on Capitol Hill and throughout the healthcare system.

Two Long Island University pharmacists are reversing the usual course of MTM. Instead of waiting for patients and prescriptions to come to the pharmacy, they are taking MTM to patients.

The CDC found that just 4 classes of prescription drugs are responsible for more than two-thirds of drug-related hospitalizations in older patients.

FDA approved ruxolitinib (Jakafi), a twice-daily tablet, indicated for the treatment of myelofibrosis, a rare bone marrow disease that affects less than 200,000 people in the United States.

One area that has remained cloudy for prescribers and patients is: "How much does this medication actually cost?"

FDA has approved alendronate sodium (Binosto, EffRx Pharmaceuticals) effervescent tablets, the first effervescent osteoporosis treatment in a buffered solution.

Teva/IVAX Pharmaceuticals gained FDA approval for the first generic version of Lexapro (Forest) to treat both depression and generalized anxiety disorder in adults. The company will have 180 days to exclusively sell the product.

The FDA's Center for Drug Evaluation and Research (CDER) released a new draft guidance on how it develops and classifies drug-safety issues.

The National Community Pharmacists Association (NCPA) applauded U.S. Congressional representatives for seeking a hearing on the role of pharmacy benefit managers (PBMs) in Medicare Part D.

FDA approved a dose counter for use with albuterol sulfate (ProAir HFA, Teva Respiratory) for prevention of bronchospasm, the company announced.

The Colon Cancer Alliance and makers of Dulcolax products are working together again to remind people that March is Colorectal Cancer Awareness Month and to urge them to schedule a screening,

Pharmacists are already getting more heavily involved in medication therapy management and counseling services. Now, a company is also urging them to offer patients nutritional guidance as well.

David D. Pope, PharmD, CDE and editor in chief of CreativePharmacist.com, has developed another online tool to help pharmacists work with the overall healthcare of their patients.

The International Pharmaceutical Federation will celebrate its 100th anniversary at the Centennial Congress of Pharmacy and Pharmaceutical Sciences October 3 through 8 in Amsterdam, The Netherlands.

FDA approved the first cell-based product made from allogeneic human cells and bovine collagen (Gintuit, Organogenesis) for the treatment of oral mucogingival conditions in adults, the agency announced Friday.

The Centers for Disease Control and Prevention is calling for more appropriate use of antibiotics to combat historically high levels of mortality associated with Clostridium difficile infections in hospitals and other healthcare settings.

A treat-and-extend regimen of intravitreal bevacizumab (Avastin, Genentech) produced ?significant visual improvements? for eyes with neovascular age-related macular degeneration, according to an article published in the March issue of the American Journal of Ophthalmology.

Antipsychotic medication should be used on elderly dementia patients only as a last resort, authors of a recent study said, but they found that some antipsychotics are more dangerous than others after examining data from thousands of nursing-home residents aged 65 or older.

An FDA advisory panel voted 12-2 to recommend approval of aclidinium bromide (Forest Laboratories and Almirall SA) 400 µg twice daily for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

FDA has approved lucinactant (Surfaxin, Discovery Labs) for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. Surfaxin is the first synthetic, peptide-containing surfactant approved for use in neonatal medicine.

New guidelines for the use of the quadrivalent human papillomavirus vaccine, published by the American Academy of Pediatrics, recommend for the first time vaccinating adolescent boys as well as girls.

Between Dec. 20, 2011, and January and Feb. 20, 2012, a CVS pharmacy in Chatham, N.J., dispensed tamoxifen tablets instead of 0.5 mg chewable fluoride pills. The mix-up could have affected as many as 50 children, but only 13 prescriptions were found to definitely be affected, according to a CVS statement.

Closed pharmacy networks are back and pharmacies are fighting them. That's the gist of a suit filed by four independent pharmacies against the federal government in U.S. District Court for the Eastern District of North Carolina last week.

The National Community Pharmacists Association is urging the Centers for Medicare and Medicaid Services to stop requiring duplicative fees from pharmacists